Kidway's age, and preexisting heart failure. Continuous hemodynamic assessment would be necessary given Mrs. Also, measurement of her creatinine level would be necessary since her kidney's function would need to be assessed. Digoxin immune Fab is indicated for the treatment of life threatening digoxin toxicity in patients with manifestations of severe toxicity. Correcting any electrolyte imbalances: correcting her hypokalemia (2.1 mEq/L, normal potassium level is 3.5-5 mEq/L) would be necessary since it can cause arrhythmias and impacts the cardiac system. DigiFab 40 mg vials replace Digibind 38 mg vials discontinued by the manufacturer in 2011.

Kidway has been regularly taking digoxin, her toxicity is most likely chronic due to the long half-life. GI decontamination would be necessary for an acute overdose. INDICATIONS AND USAGE DIGIBIND, Digoxin Immune Fab (Ovine), is indicated for treatment of potentially life-threatening digoxin intoxication.3 Although designed specifically to treat life-threatening digoxin overdose, it has also been used successfully to treat life-threatening digitoxin overdose. Supportive treatment would consist of rehydration with IV fluids, oxygenation and possible ventilator support, discontinuation of the drug, and correction of any electrolyte imbalances. Digibind is a sterile freeze-dried powder of antigen binding fragments (Fab) obtained from antidigoxin antibodies raised in sheep.

Digibind Injection belongs to a group of medicines called the antigen binding fragments. Digoxin immune fab (Digibind) is the antidote for digitalis toxicity and is the first line treatment. Digibind Injection is an antidote used to treat life-threatening digoxin or digitoxin overdose. Digibind/digifab and Atropine: Digoxin toxicity treatment is mainly guided by the signs and symptoms, not the digoxin level alone.

Digibind antidote